TRY NOW

Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Latest News

Latest on Twitter

Latest on Linked In

News Articles

The latest news articles from Life Sciences Research
The future of COPD treatment
The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine
Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks
Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

Thank you for your readership!

Thomson Reuters Life Sciences Connect has moved to a new location on our IP & Science website, and this site is no longer updated or ...

Superbugs and Superdrugs, Pushing Financial Incentives and Collaborative Incentives to Accelerate Clinical Success – SMi’s 18th Annual Conference, London, UK, March 16-17, 2016

Richard Bax (Transcrip Partners) introduced SMi’s 18th Annual Superbug and Superdrug Conference with an overview of where antibiotic development fits in the broader realm of ...

Gleevec: A Successful Life and Impact of Generics

The first oncology drug to be developed with rational drug design to target malignant cells, Novartis’ tyrosine kinase inhibitor (TKI) Gleevec (imatinib) has been hailed ...